United Kingdom National External Quality Assessment Service (UK NEQAS) for Molecular Genetics choose PathXL digital pathology software to run a national scheme to assess consistency of tumour analysis for molecular pathology testing, as part of...

SAN DIEGO, March 2, 2015 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of cell-free circulating tumor DNA and circulating tumor cells (CTCs), today announced that...

By Roxanne Nelson - FDA Approves Cologuard for Colorectal Cancer Screening. Medscape. Aug 11, 2014. August 11, 2014The US Food and Drug Administration (FDA) today approved Cologuard (Exact Sciences Corporation), a stool-based...